Centers | ||
test | Therapeutic Accelerator Program (TAP) | VMCC, University of Michigan |
sfgd |
Test |
The VMCC is an on-campus core facility for the design and synthesis of drug-like molecules and diagnostic probes used in biomedical investigations. Our Mission: To assist biomedical researchers in translating novel therapeutic hypotheses into... |
Partnerships |
Events |
Jobs |
Eisiai Partners with Johns Hopkins Brain Science InstituteEisiai Partners with Johns Hopkins Brain Science Institute ("BSi") an institute which is part of Johns Hopkins University to develop new drugs for neurological diseases. Under this joint collaboration, BSi will provide validated targets to Eisai... View all Merck Establishes New Center in San Diego with Academic ResearchersMerck Pharmaceuticals has committed to fund $90 million over period of seven years to establish California Institute for Biomedical Research (Calibr) in San Diego, California. The new center will be led by Peter Schulz from the Scripps Research... View all Evotec and Yale University to collaborate on cancer therapyEvotec announced a research collaboration, TargetDBR (DNA Break Repair), with the laboratories of Prof. Peter Glazer and Prof. Ranjit Bindra at Yale School of Medicine. The objective of this collaboration is to identify novel mechanisms, targets and... View all |
The ABE 2023 Annual Meeting will take place on April 30-May 4 at the Kiawah Island Resort in... ![]() On behalf of the American Society for Reproductive Immunology, it is with great enthusiasm that we... |
Post-doctoral Research Fellow in Gene Therapy
id: 22560 Postdoctoral Fellowship in Metastatic Cancer Research
id: 22561 Postdoctoral Fellowship in Obesity and Metabolism Research
id: 22564 Postdoc
id: 22536 |